EC Number   |
Application |
Reference |
|---|
    6.3.2.4 | analysis |
assay method for screening for effectors of alanine racemase and/or D-alanine:D-alanine ligase |
-, 1227 |
| 6.3.2.4 | drug development |
DDL is an important drug target for the development of antibacterial agents |
743944 |
| 6.3.2.4 | drug development |
the enzyme is a target for antibiotic inhibitor development, overview |
691244 |
| 6.3.2.4 | drug development |
the enzyme is a target for drug development to combat against Mycobacterium tuberculosis (Mtb) |
-, 745827 |
| 6.3.2.4 | drug development |
the enzyme is a target for drug development. Acinetobacter baumannii is emerging as a multidrug-resistant nosocomial pathogen, that causes a number of diseases, including pneumonia, bacteremia, meningitis, and skin infections |
745534 |
| 6.3.2.4 | drug development |
the enzyme is an attractive and viable target in the search for effective antimicrobial drugs |
728577 |
| 6.3.2.4 | drug development |
the enzyme is an attractive target for development of antimicrobial drugs |
727157 |
| 6.3.2.4 | synthesis |
D-alanine-D-alanine ligase is a biocatalyst for synthesizing D-amino acid dipeptides, use of a thermostable ATP regeneration system |
674956 |
